CytoDyn
Financial ratios & Valuation

Historical Multiples (2015 – 2024)

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 TTM Median
Valuation Ratios
Price/Earnings ratio
-2.19-3.67-3.21-1.75-1.89-8.82-6.92-0.79-2.74-3.10-0.95-1.89
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/A865.21N/AN/A4.44KN/A
Price/Book Value ratio
-5.329.24-75.05-6.47-11.93-504.17-57.31-2.43-1.99-1.32-1.57-11.93
Price/Cash Flow ratio
-4.73-3.80-3.09-2.84-2.10-18.17-10.24-2.96-8.71-14.07-5.59-18.17
Price/Free Cash Flow ratio
-4.72-3.80-3.09-2.84-2.10-18.16-10.23-2.96-8.71-14.07-5.59-18.16
Price/Earnings Growth ratio
-0.030.090.10-0.030.07-0.140.58-0.010.030.060.030.03
Dividend Yield
N/AN/AN/AN/AN/AN/A0.02%N/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/A80.07%N/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/A-27035.33%N/AN/A-239980.48%N/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/A-79255.63%N/AN/A-465275.60%N/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/A-108331.95%N/AN/A-465275.60%N/A
Effective Tax Rate
-3.34%0.24%8.40%3.37%4.79%-13.97%-12.50%-36.68%-16.27%N/AN/AN/A
Return on Assets
-554.07%-186.44%-319.83%-989.15%-269.16%-280.68%-131.75%-987.36%-706.90%-447.56%-2696.67%-280.68%
Return On Equity
242.47%-251.86%2335.29%368.28%630.31%5715.96%827.94%305.26%72.89%42.68%233.25%5715.96%
Return on Capital Employed
324.12%-207.49%-1429.85%388.02%922.83%-1241.33%511.07%76.52%37.39%24.72%85.10%85.10%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.05N/A
Quick Ratio
0.193.210.990.190.200.390.230.080.090.120.010.39
Cash ratio
0.092.690.280.070.090.320.220.030.020.030.010.32
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/A-26.623.43K18.98K123.47KN/AN/AN/A-26.62
Operating Cycle
N/AN/AN/AN/AN/AN/AN/A123.47KN/AN/AN/AN/A
Days of Payables Outstanding
N/A2.49K4.26K16.23K4.76K5.28K13.38K468.12K130.82K372.06KN/A5.28K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/A-344.64KN/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.91N/A0.13N/A0.390.300.471.243.112.6717.390.39
Debt Equity Ratio
-0.39N/A-0.95N/A-0.92-6.28-2.98-0.38-0.32-0.25-1.06-6.28
Long-term Debt to Capitalization
-0.32N/AN/AN/A-0.051.41N/AN/A-0.00N/AN/A-0.05
Total Debt to Capitalization
-0.66N/A-23.72N/A-12.231.181.50-0.62-0.47-0.34N/A-12.23
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-9.21N/A
Cash Flow to Debt Ratio
-2.81N/A-25.25N/A-6.12-4.41-1.87-2.14-0.71-0.36N/A-6.12
Company Equity Multiplier
-0.431.35-7.30-0.37-2.34-20.36-6.28-0.30-0.10-0.09-0.06-2.34
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/A-292.19N/AN/A-794.41N/A
Free Cash Flow / Operating Cash Flow Ratio
1.001.001.0011.001.001.001110.991.00
Cash Flow Coverage Ratio
-2.81N/A-25.25N/A-6.12-4.41-1.87-2.14-0.71-0.36N/A-6.12
Short Term Coverage Ratio
-7.35N/A-25.25N/A-6.48-9.62-1.87-2.14-0.72-0.36-0.72-6.48
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/A-0.13%N/AN/AN/AN/AN/A